(Q42241661)

English

Evidence that the purported dopaminergic agonist (3,4-dihydroxyphenylimino)-2-imidazolidine (DPI) may reduce rat striatal dopamine turnover by an α2-adrenergic mechanism

scientific article published on June 16, 1982

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Evidence that the purported dopaminergic agonist (3,4-dihydroxyphenylimino)-2-imidazolidine (DPI) may reduce rat striatal dopamine turnover by an alpha 2-adrenergic mechanism (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Evidence that the purported dopaminergic agonist (3,4-dihydroxyphenylimino)-2-imidazolidine (DPI) may reduce rat striatal dopamine turnover by an α2-adrenergic mechanism (English)

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6126370

10 August 2023

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

author name string

J. C. van Oene

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6126370

10 August 2023

H. A. Houwing

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6126370

10 August 2023

A. S. Horn

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6126370

10 August 2023

language of work or name

0 references

publication date

1 June 1982

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

16 June 1982

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6126370

10 August 2023

full work available at URL

https://api.elsevier.com/content/article/PII:0014299982906033?httpAccept=text/xml

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

https://api.elsevier.com/content/article/PII:0014299982906033?httpAccept=text/plain

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

European Journal of Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

81

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

75-87

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

R 28935 and prazosin: Effects on central and peripheral alpha-adrenoreceptor activity and on blood pressure

1

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain

2

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents

3

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Norepinephrine-dopamine interactions and behavior

4

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

A functional basis for classification of α-adrenergic receptors

5

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

The action of microelectrophoretically applied (3,4-dihydroxy-phenylamino)-2-imidazoline (DPI) on single cortical neurones

6

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Hyperpolarizing 'alpha 2'-adrenoceptors in rat sympathetic ganglia

9

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Catecholamine receptors on locus coeruleus neurons: Pharmacological characterization

10

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Comparative study on the serotonin antagonism of amide derivatives of lysergic acid and of ergot alkaloids

11

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

The nucleus accumbens of rats and dopaminergic mechanisms regulating locomotor behaviour

12

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Excitation-mediating and inhibition-mediating dopamine-receptors: A new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data

13

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Multiple receptors for brain dopamine in behavior regulation: Concept of dopamine-e and dopamine-i receptors

14

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

The importance of serotonergic mechanisms for the induction of hyperactivity by amphetamine and its antagonism by intra-accumbens (3,4-dihydroxy-phenylamino)-2-imidazoline (DPI)

15

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

The roles of noradrenaline and dopamine in contraversive circling behaviour seen after unilateral electrolytic lesions of the locus coeruleus.

16

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Effect of dihydroxy-2-aminotetralin derivatives on dopamine metabolism in the rat striatum

17

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

The inhibition of catecholamine biosynthesis by apomorphine.

18

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Inhibition by dopamine agonists of dopamine accumulation following γ-hydroxybutyrate treatment

19

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Effects of ring substitution on the pre- and postjunctional alpha-adrenergic activity of aryliminoimidazolidines

20

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Multiple receptors for dopamine

22

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Presence of a particular subpopulation of dopamine receptors within the septal nuclei: a behavioural study on cats

25

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Direct biochemical demonstration of two types of α-adrenoreceptor in rat brain

26

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Further studies on the possible interaction between dopamine and noradrenaline containing neurons in the brain

28

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Antidopaminergic properties of yohimbine

31

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Changes in dopamine and DOPAC following systemic administration of apomorphine and 3,4-dihydroxyphenylamino-2-imidazoline (DPI) in rats

32

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Structure activity relationship for central and peripheral alpha adrenergic activities of imidazoline derivatives

33

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

(3,4-Dihydroxy-phenylamino)-2-imidazoline (DPI), a new potent agonist at dopamine receptors mediating neuronal inhibition

34

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Involvement of both dopaminergic and alpha-adrenergic receptors in the hypomotility induced by dibenzoyl-6,7-ADTN

35

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine

36

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Mini-review. The postsynaptic alpha 2-adrenoreceptor

37

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Correlations between central hypotensive and peripheral hypertensive effects of structurally dissimilar alpha-adrenoceptor agonists

38

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Dopaminergic neurons: An in vivo system for measuring drug interactions with presynaptic receptors

39

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Dopaminergic prodrugs: brain concentrations and neurochemical effects of 5,6- and 6,7-ADTN after administration as dibenzoyl esters

40

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Rapid concurrent automated fluorimetric assay of noradrenaline, dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid and 3-methoxytyramine in milligram amounts of nervous tissue after isolation on Sephadex G10

41

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Determination of picomole amounts of dopamine, noradrenaline, 3,4-dihydroxyphenylalanine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindolacetic acid in nervous tissue after one-step purification on Sephadex G-10, using high-per

42

1 reference

10.1016/0014-2999(82)90603-3

https://api.crossref.org/works/10.1016/0014-2999(82)90603-3

10 August 2023

Identifiers

10.1016/0014-2999(82)90603-3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42241661&oldid=1951008349"